2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association …

BR Haugen, EK Alexander, KC Bible, GM Doherty… - Thyroid, 2016 - liebertpub.com
Background: Thyroid nodules are a common clinical problem, and differentiated thyroid
cancer is becoming increasingly prevalent. Since the American Thyroid Association's …

Interconnection between circadian clocks and thyroid function

K Ikegami, S Refetoff, E Van Cauter… - Nature Reviews …, 2019 - nature.com
Circadian rhythmicity is an approximately 24-h cell-autonomous period driven by
transcription–translation feedback loops of specific genes, which are referred to as 'circadian …

Thyroid carcinoma, version 2.2022, NCCN clinical practice guidelines in oncology

RI Haddad, L Bischoff, D Ball, V Bernet… - Journal of the National …, 2022 - jnccn.org
Differentiated thyroid carcinomas is associated with an excellent prognosis. The treatment of
choice for differentiated thyroid carcinoma is surgery, followed by radioactive iodine ablation …

Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association …

DS Cooper, GM Doherty, BR Haugen, RT Kloos… - Thyroid, 2009 - liebertpub.com
Background: Thyroid nodules are a common clinical problem, and differentiated thyroid
cancer is becoming increasingly prevalent. Since the publication of the American Thyroid …

[HTML][HTML] Antitumor activity of lenvatinib (e7080): an angiogenesis inhibitor that targets multiple receptor tyrosine kinases in preclinical human thyroid cancer models

O Tohyama, J Matsui, K Kodama, N Hata-Sugi… - Journal of thyroid …, 2014 - hindawi.com
Inhibition of tumor angiogenesis by blockading the vascular endothelial growth factor
(VEGF) signaling pathway is a promising therapeutic strategy for thyroid cancer. Lenvatinib …

[HTML][HTML] Comprehensive analysis of the transcriptional and mutational landscape of follicular and papillary thyroid cancers

SK Yoo, S Lee, S Kim, HG Jee, BA Kim, H Cho… - PLoS …, 2016 - journals.plos.org
Follicular thyroid carcinoma (FTC) and benign follicular adenoma (FA) are indistinguishable
by preoperative diagnosis due to their similar histological features. Here we report the first …

[HTML][HTML] Therapeutic advances in anaplastic thyroid cancer: a current perspective

S Saini, K Tulla, AV Maker, KD Burman, BS Prabhakar - Molecular cancer, 2018 - Springer
Thyroid cancer incidence is increasing at an alarming rate, almost tripling every decade. In
2017, it was the fifth most common cancer in women. Although the majority of thyroid tumors …

Management guidelines for patients with thyroid nodules and differentiated thyroid cancer: The American Thyroid Association Guidelines Taskforce

DS Cooper, GM Doherty, BR Haugen, RT Kloos… - Thyroid, 2006 - liebertpub.com
THYROID NODULES are a common clinical problem. Epidemiologic studies have shown
the prevalence of palpable thyroid nodules to be approximately 5% in women and 1% in …

Differentiated thyroid cancer—treatment: state of the art

B Schmidbauer, K Menhart, D Hellwig… - International journal of …, 2017 - mdpi.com
Differentiated thyroid cancer (DTC) is a rare malignant disease, although its incidence has
increased over the last few decades. It derives from follicular thyroid cells. Generally …

[HTML][HTML] BRAF mutation in thyroid cancer

M Xing - Endocrine-related cancer, 2005 - erc.bioscientifica.com
Genetic alteration is the driving force for thyroid tumorigenesis and progression, based upon
which novel approaches to the management of thyroid cancer can be developed. A recent …